Five things to do in your 20s and 30s to reduce your risk of preventable cancer

by Sarah Allinson,The ConversationCredit: AI-generated imageMost of us don't think about cancer when we're in our 20s and 30s. But recent research has shown that people born after 1990 a

Updated on: February 23,2024

Five things to do in your 20s and 30s to reduce your risk of preventable cancer

by Sarah Allinson,The ConversationCredit: AI-generated imageMost of us don't think about cancer when we're in our 20s and 30s. But recent research has shown that people born after 1990 a

Updated on:February 23,2024

Exercise may help reduce long-term side effects of chemotherapy for breast cancer patients

by University of AmsterdamCredit: CC0 Public DomainAfter treatment for breast cancer, most women suffer side effects such as fatigue, not feeling physically fit and cognitive issues. This can oft

Updated on: February 24,2024

Exercise may help reduce long-term side effects of chemotherapy for breast cancer patients

by University of AmsterdamCredit: CC0 Public DomainAfter treatment for breast cancer, most women suffer side effects such as fatigue, not feeling physically fit and cognitive issues. This can oft

Updated on:February 24,2024

New drug delays progression of glioma, a deadly brain cancer, during clinical trial

by Denise Heady,University of California, Los AngelesCredit: Unsplash/CC0 Public DomainIn an international study co-led by UCLA, scientists have shown that a new targeted therapy drug can extend

Updated on: January 15,2024

New drug delays progression of glioma, a deadly brain cancer, during clinical trial

by Denise Heady,University of California, Los AngelesCredit: Unsplash/CC0 Public DomainIn an international study co-led by UCLA, scientists have shown that a new targeted therapy drug can extend

Updated on:January 15,2024

FDA approves first CAR T-cell therapy for adults with leukemia or lymphoma

by Lori SolomonThe U.S. Food and Drug Administration has approved Bristol Myers Squibb's Breyanzi (lisocabtagene maraleucel [liso-cel]) as the first CD19-directed chimeric antigen receptor (CAR) T

Updated on: March 30,2024

FDA approves first CAR T-cell therapy for adults with leukemia or lymphoma

by Lori SolomonThe U.S. Food and Drug Administration has approved Bristol Myers Squibb's Breyanzi (lisocabtagene maraleucel [liso-cel]) as the first CD19-directed chimeric antigen receptor (CAR) T

Updated on:March 30,2024

Trial finds that adagrasib demonstrates durable clinical activity in patients with KRAS-G12C mutations

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe oral, selective KRAS G12C inhibitor KRAS-G12C inhibitor adagrasib demonstrated durable clinical activity,

Updated on: January 04,2024

Trial finds that adagrasib demonstrates durable clinical activity in patients with KRAS-G12C mutations

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe oral, selective KRAS G12C inhibitor KRAS-G12C inhibitor adagrasib demonstrated durable clinical activity,

Updated on:January 04,2024

Small molecule inhibitors show early-stage promise against YAP fusion-driven cancers

byCincinnati Children's Hospital Medical CenterIn an early proof-of-concept success, a team led by experts at Cincinnati Children's reports that mice induced to develop brain tumors feat

Updated on: January 11,2024

Small molecule inhibitors show early-stage promise against YAP fusion-driven cancers

byCincinnati Children's Hospital Medical CenterIn an early proof-of-concept success, a team led by experts at Cincinnati Children's reports that mice induced to develop brain tumors feat

Updated on:January 11,2024

Researchers synthesize chimeric peptide that elicits antitumor activity for cancer immunotherapy

by Science China PressThepeptide Pal-DMPOP consists a peptide inhibitor of CD47/SIRPα, a D-peptide inhibitor of PD-1/PD-L1, and a palmitic acid tail conjugated at its N-terminal through a P

Updated on: February 23,2024

Researchers synthesize chimeric peptide that elicits antitumor activity for cancer immunotherapy

by Science China PressThepeptide Pal-DMPOP consists a peptide inhibitor of CD47/SIRPα, a D-peptide inhibitor of PD-1/PD-L1, and a palmitic acid tail conjugated at its N-terminal through a P

Updated on:February 23,2024

Immune landscape and response to oncolytic virus-based immunotherapy

by Frontiers JournalsCredit:Frontiers of Medicine(2024). DOI: 10.1007/s11684-023-1048-0Oncolytic virus (OV)-based immunotherapy has emerged as a promising strategy for cancer treatment, of

Updated on: August 28,2024

Immune landscape and response to oncolytic virus-based immunotherapy

by Frontiers JournalsCredit:Frontiers of Medicine(2024). DOI: 10.1007/s11684-023-1048-0Oncolytic virus (OV)-based immunotherapy has emerged as a promising strategy for cancer treatment, of

Updated on:August 28,2024

Study finds link between Medicaid expansion and equity in cancer care

by Anne Doerr,Yale UniversityCredit: CC0 Public DomainRacial disparities in timely cancer treatment disappeared in states that expanded Medicaid under the Affordable Care Act (ACA), according to

Updated on: July 04,2024

Study finds link between Medicaid expansion and equity in cancer care

by Anne Doerr,Yale UniversityCredit: CC0 Public DomainRacial disparities in timely cancer treatment disappeared in states that expanded Medicaid under the Affordable Care Act (ACA), according to

Updated on:July 04,2024

Study confirms pancreatic cancer rates rising faster in women than men

by Cedars-Sinai Medical CenterAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainIn a large-scale nationwide study, investigators from Ceda

Updated on: January 30,2024

Study confirms pancreatic cancer rates rising faster in women than men

by Cedars-Sinai Medical CenterAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainIn a large-scale nationwide study, investigators from Ceda

Updated on:January 30,2024

Here's what you can eat and avoid to reduce your risk of bowel cancer

by Suzanne Mahady,The ConversationCredit: ready made from PexelsAustralia has one of thehighest rates of bowel cancer in the world. In 2017, bowel cancer was thesecond most common ca

Updated on: May 13,2024

Here's what you can eat and avoid to reduce your risk of bowel cancer

by Suzanne Mahady,The ConversationCredit: ready made from PexelsAustralia has one of thehighest rates of bowel cancer in the world. In 2017, bowel cancer was thesecond most common ca

Updated on:May 13,2024

Attacking metastatic prostate cancer early with combination treatment approach improves outcomes in preliminary study

by Denise Heady,University of California, Los AngelesProstate cancer cells. Credit: NIH Image GalleryA team of UCLA Health Jonsson Comprehensive Cancer Center investigators has shown the combina

Updated on: March 30,2024

Attacking metastatic prostate cancer early with combination treatment approach improves outcomes in preliminary study

by Denise Heady,University of California, Los AngelesProstate cancer cells. Credit: NIH Image GalleryA team of UCLA Health Jonsson Comprehensive Cancer Center investigators has shown the combina

Updated on:March 30,2024